Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen ... | April 3, 2023

Related Keywords

Denmark , United States , Japan , Switzerland , District Of Columbia , Boston , Massachusetts , Copenhagen , Køavn , Australia , United Kingdom , Canada , Swiss , Danish , Zealand Pharma , Henriette Wennicke , Anna Krassowska , Adam Steensberg , Investor Relations Corporate Communications , Danish Financial Supervisory Authority , Financial Services , Danish Financial Supervisory Authority The Prospectus , Swiss Financial Services , European Union Withdrawal , Commission Delegated Regulation , Nasdaq Copenhagen , Pro Forma Financial , Unaudited Pro Forma Financial Information , V Go Activity , Vice President , Investor Relations , Executive Vice President , Chief Financial , Chief Executive , South Africa , Excluded Territories , Member State , Prospectus Regulation , European Union , Kingdom Prospectus , Member States , United Kingdom Prospectus Regulation , Markets Act , Financial Promotion , Swiss Financial Services Act , Zealand Pharmaas Stock Exchange , News , Information , Press Release , Company , Announcement , 3 , 023 , Zealand , Dharma , Ublishes , Listing , Prospectus , Egarding , Admission , O , Trading , End , Official , F , Few , Hares , N , Nasdaq , Openhagen Zeal Dk0060257814 ,